-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Corvus Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2024.
- Corvus Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 49 M shares, a 5.33% increase year-over-year.
- Corvus Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 48 M shares, a 3.16% increase from 2022.
- Corvus Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 46.6 M shares, a 11.2% increase from 2021.
- Corvus Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 41.9 M shares, a 42% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)